Azithromycin SR
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pneumonia, Community-Acquired
Conditions
Pneumonia, Community-Acquired
Trial Timeline
Sep 1, 2006 → May 1, 2007
NCT ID
NCT00360295About Azithromycin SR
Azithromycin SR is a phase 3 stage product being developed by Pfizer for Pneumonia, Community-Acquired. The current trial status is completed. This product is registered under clinical trial identifier NCT00360295. Target conditions include Pneumonia, Community-Acquired.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00998309 | Pre-clinical | Completed |
| NCT00393835 | Phase 3 | Completed |
| NCT00360464 | Phase 3 | Completed |
| NCT00360295 | Phase 3 | Completed |
Competing Products
20 competing products in Pneumonia, Community-Acquired